Treating human cancer with an NIDDM drug: Metformin suppresses the expression of c-Jun via up regulation of its target gene , 5/August/2014, 12.14 pm

Differentiation Therapy for Embryonal Rhabdomyosarcoma: PTEN inhibits the activation of satellite cells and the development of Rhabdomyosarcoma via down regulation of its target gene, 5/August/2014, 11.11 am
August 5, 2014
Mechanistic insights into Metastatic tumor suppression: Oncogenic KRAS suppresses the expression of tumor suppressor PDCD4 via down regulation of its target gene, 6/August/2014, 6.19 am
August 6, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, Treating human cancer with an NIDDM drug: Metformin suppresses the expression of c-Jun via up regulation of its target gene, 5/August/2014, 12.15 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

 * Research cooperation

Comments are closed.